home / lobbying / lobbying_filings_raw

lobbying_filings_raw: 845a75ad-9d6a-413b-8eaa-e9e01c623a32

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
845a75ad-9d6a-413b-8eaa-e9e01c623a32 Q2 15042 FOLEY & LARDNER LLP 120688 ROMARK LABORATORIES, LC 2011 second_quarter 2011-07-19T17:29:34.710000-04:00   0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/845a75ad-9d6a-413b-8eaa-e9e01c623a32/", "filing_uuid": "845a75ad-9d6a-413b-8eaa-e9e01c623a32", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2011, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/845a75ad-9d6a-413b-8eaa-e9e01c623a32/print/", "filing_document_content_type": "text/html", "income": null, "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Theodore Bornstein, Attorney", "dt_posted": "2011-07-19T17:29:34.710000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "3000 K ST NW, Suite 500", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20007", "registrant": {"id": 15042, "url": "https://lda.senate.gov/api/v1/registrants/15042/", "house_registrant_id": 33563, "name": "FOLEY & LARDNER LLP", "description": "law firm", "address_1": "3000 K Street NW", "address_2": "Suite 600", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20007", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JARED B. RIFIS", "contact_telephone": "+1 202-295-4154", "dt_updated": "2026-01-30T13:33:06.842869-05:00"}, "client": {"id": 120688, "url": "https://lda.senate.gov/api/v1/clients/120688/", "client_id": 1004696, "name": "ROMARK LABORATORIES, LC", "general_description": "Biotechnology development", "client_government_entity": false, "client_self_select": false, "state": "FL", "state_display": "Florida", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2009-11-24"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Sale of new anti-viral drug", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43539, "prefix": "mr", "prefix_display": "MR.", "first_name": "SCOTT", "nickname": null, "middle_name": "L", "last_name": "KLUG", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 10833, "prefix": "mr", "prefix_display": "MR.", "first_name": "THEODORE", "nickname": null, "middle_name": "H", "last_name": "BORNSTEIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Sale of new anti-viral drug", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43539, "prefix": "mr", "prefix_display": "MR.", "first_name": "SCOTT", "nickname": null, "middle_name": "L", "last_name": "KLUG", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 10833, "prefix": "mr", "prefix_display": "MR.", "first_name": "THEODORE", "nickname": null, "middle_name": "H", "last_name": "BORNSTEIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 33563 FL   US US Biotechnology development 0 0 2239742   normalized_name_state 0.9

Links from other tables

  • 2 rows from filing_uuid in lobbying_activities
  • 2 rows from filing_uuid in lobbying_lobbyists
  • 0 rows from filing_uuid in lobbying_affiliated_orgs
Powered by Datasette · Queries took 30.16ms